MSF Access

With no validated treatments or vaccines yet, and limited diagnostics for Bundibugyo virus disease, R&D and funding must embed transparent and enforceable conditions from the outset to guarantee timely, sustainable access to affordable medical tools for the most affected communities.

Read our statement sharing principles to follow for equitable access to medical tools for Ebola disease caused by Bundibugyo virus: https://msfaccess.org/principles-equitable-access-medical-tools-ebola-disease-caused-bundibugyo-virus?utm_source=fb

During the 79th World Health Assembly this week, MSF representatives will address critical health issues at the World Health Assembly this week, calling for urgent action on:

🦠Antimicrobial resistance
🩺Noncommunicable diseases
😷Pandemic preparedness & response
💉Vaccines

Read the statements here:

MSF statements at WHO World Health Assembly 79th session MSF statements on access to healthcare products at 79th World Health Assembly

📢This World Health Assembly , we’re calling for countries, donors, and other global health stakeholders to urgently dismantle the barriers blocking access to lifesaving vaccination in conflict-affected settings by:

📌Removing administrative and bureaucratic blockages and strengthening collaboration between health authorities, humanitarian partners, and communities to ensure timely and unhindered access to vaccine supplies and hard-to-reach areas.

📌Ensuring flexible and adapted delivery models to reach children in conflict settings and stop delays in people’s access to lifesaving vaccines.

📌Dedicating sustained and agile financing to ensure immunisation activities reach people in the world’s most fragile areas.

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings Sustained funding, timely and unhindered access to vaccine supplies, and flexible, secure and adapted delivery models required to reach more people with lifesaving vaccination in world’s most fragile areas

Did you know that the Pandemic Agreement, signed one year ago, is still on hold because of an annex? Enter the PABS annex!

Without the Pathogen Access and Benefit Sharing (PABS) annex, countries cannot ratify or implement the Pandemic Agreement, but major disagreements remain unresolved. Governments must advance negotiations toward a strong multilateral PABS framework to ensure access is based on enforceable benefit‑sharing.

“For decades, MSF has witnessed communities in resource-limited settings affected by deadly outbreaks, including Ebola and more recently COVID-19, often receive no or severely delayed access to lifesaving medical tools. Communities who share critical samples and data, and those most at risk during outbreaks and health emergencies cannot anymore be the last to benefit from medical innovation,” highlighted Dr Maria Guevara, MSF International Medical Secretary. “We strongly urge governments to act now.”

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all MSF calls on countries to prepare for early implementation of the Pandemic Agreement.

Vaccines are one of the most successful and widespread public health tools used to protect against disease, but they’re not always affordable, adapted to context, or accessible to everyone who needs them. And, in some cases, there are simply no vaccines available yet to protect against certain diseases.

With 14.3 million children having missed out on receiving any vaccination in 2024, it’s time to close the gap in vaccine access.

This World Immunisation Week and beyond, MSF teams in Pakistan, France, South Sudan, Nigeria, and Sudan share access and innovation advancements that, if achieved in the years to come, could result in lifesaving vaccines reaching more people around the world.

A shot of urgency: Five key pathways to reach more people with lifesaving vaccines This World Immunisation Week and beyond, MSF teams in Pakistan, France, South Sudan, Nigeria, and Sudan share access and innovation advancements that, if achieved in the years to come, could result in lifesaving vaccines reaching more people around the world.